Jump to content
  • Sign Up
0
Scott Adams

Alvine Pharmaceuticals Announces Upcoming Presentation of Phase 2a ALV003 Data ... - MarketWatch (press release)

Rate this topic

Recommended Posts

Alvine Pharmaceuticals Announces Upcoming Presentation of Phase 2a ALV003 Data ...

MarketWatch (press release)

SAN CARLOS, CA, Sep 22, 2011 (MARKETWIRE via COMTEX) -- Alvine Pharmaceuticals, Inc. today announced that data from its Phase 2a trial of ALV003 in patients with celiac disease will be presented at the 19th United European Gastroenterology Week (UEGW) ...

and more »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×